Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Thorne

Showing results (401-410 of 405) with videos related to

Pageof 41
Sort By:
You have reached the last page of results.This site can display upto 405 results.
Ocular Immunology and Inflammation|April 15, 2025
Effectiveness of Frequently Used TNF Inhibitors vs. Conventional Immunosuppressive Therapies for Noninfectious UveitisSapna S Gangaputra, Craig W Newcomb, Gui-Shuang Ying, et al.
The Lancet. HIV|January 27, 2019
Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studiesKeri N Althoff, Kelly A Gebo, Richard D Moore, et al.
BMJ Oncology|January 31, 2025
Use of immunosuppression and subsequent cancer incidence: cohort studyJeanine M Buchanich, Craig W Newcomb, Terri L Washington, et al.
Ophthalmology|July 27, 2023
Use of Immunosuppression and the Risk of Subsequent Overall or Cancer MortalityJohn H Kempen, Craig W Newcomb, Terri L Washington, et al.
Ocular Immunology and Inflammation|April 7, 2020
The Collaborative Ocular Tuberculosis Study (COTS) Consensus (CON) Group Meeting ProceedingsRupesh Agrawal, Ilaria Testi, Sarakshi Mahajan, et al.
Pageof 41

Showing results (401-410 of 405) with videos related to

Sort By:
Pageof 41
You have reached the last page of results.This site can display upto 405 results.
Ocular Immunology and Inflammation|April 15, 2025
Effectiveness of Frequently Used TNF Inhibitors vs. Conventional Immunosuppressive Therapies for Noninfectious UveitisSapna S Gangaputra, Craig W Newcomb, Gui-Shuang Ying, et al.
The Lancet. HIV|January 27, 2019
Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studiesKeri N Althoff, Kelly A Gebo, Richard D Moore, et al.
BMJ Oncology|January 31, 2025
Use of immunosuppression and subsequent cancer incidence: cohort studyJeanine M Buchanich, Craig W Newcomb, Terri L Washington, et al.
Ophthalmology|July 27, 2023
Use of Immunosuppression and the Risk of Subsequent Overall or Cancer MortalityJohn H Kempen, Craig W Newcomb, Terri L Washington, et al.
Ocular Immunology and Inflammation|April 7, 2020
The Collaborative Ocular Tuberculosis Study (COTS) Consensus (CON) Group Meeting ProceedingsRupesh Agrawal, Ilaria Testi, Sarakshi Mahajan, et al.
Pageof 41